Final Glance: Biotechnology companies
News | 11 June 2012
NEW YORK ? Shares of some top biotechnology companies were down at the close of trading: Amgen Inc. fell $1.08 or 1.6 percent, to $67.79. Biogen Idec fell $1.26 or .9 percent, to $132.26. Celgene Corp. fell $1.34 or 2.1 percent, to $63.70.
Click on the link to read the full article at CBS News
(This link will open in a new window)
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
